Abstract
112 Tunisian patients with rapidly progressing breast cancer (RPBC) were entered into a clinical trial evaluating combination chemotherapy as a primary form of treatment before surgery or radiotherapy. Three cycles of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) were administered at monthly intervals; patients were then randomized to surgery or radiotherapy to control the primary tumour, and 12 more cycles of CMF followed local/regional therapy. RPBC was sensitive to CMF; after only 3 cycles, 11% of evaluable patients showed complete remission and 78% had at least 25% diminution in tumour size. The disease-free interval (DFI) was substantially greater in this series than in a previously reported series treated by surgery and/or radiotherapy alone. No difference in DFI was found between patients randomized to receive surgery and those randomized to receive radiotherapy. Postmenopausal patients responded to CMF as well as premenopausal patients. Combination chemotherapy appears to play an important role in the control of RPBC, an aggressive malignancy often resembling inflammatory breast cancer.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonadonna G., Rossi A., Valagussa P., Banfi A., Veronesi U. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer. 1977 Jun;39(6 Suppl):2904–2915. doi: 10.1002/1097-0142(197706)39:6<2904::aid-cncr2820390677>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- Carter S. K. Surgery plus adjuvant chemotherapy--a review of therapeutic implications. I. Breast cancer. Cancer Chemother Pharmacol. 1980;4(3):147–163. doi: 10.1007/BF00254012. [DOI] [PubMed] [Google Scholar]
- Lacour J., Hourtoule F. G. La place de la chirurgie dans le traitement des formes évolutives du cancer du sein. Mem Acad Chir (Paris) 1967 Jun 14;93(19):635–643. [PubMed] [Google Scholar]
- Levine P. H., Mourali N., Tabbane F., Loon J., Terasaki P., Tsang P., Bekesi J. G. Studies on the role of cellular immunity and genetics in the etiology of rapidly progressing breast cancer in Tunisia. Int J Cancer. 1981 May 15;27(5):611–615. doi: 10.1002/ijc.2910270507. [DOI] [PubMed] [Google Scholar]
- Magrath I. T., Lwanga S., Carswell W., Harrison N. Surgical reduction of tumour bulk in management of abdominal Burkitt's lymphoma. Br Med J. 1974 May 11;2(5914):308–312. doi: 10.1136/bmj.2.5914.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stjernswärd J., Muenz L. R., von Essen C. F. Letter: Postoperative radiotherapy and breast cancer. Lancet. 1976 Apr 3;1(7962):749–749. doi: 10.1016/s0140-6736(76)93126-3. [DOI] [PubMed] [Google Scholar]
- Tabbane F., Muenz L., Jaziri M., Cammoun M., Belhassen S., Mourali N. Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia. Cancer. 1977 Jul;40(1):376–382. doi: 10.1002/1097-0142(197707)40:1<376::aid-cncr2820400153>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]